The alternative asset management arm of CLSA, Asia's leading independent brokerage and investment group
The alternative asset management arm of CLSA, Asia's leading independent brokerage and investment group
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 11, 2022
F88
|
Debt Financing | $60M | Consumer | Yes |
Sep 26, 2018
ACT Genomics
|
Series C | — | Bioinformatics | Yes |
Jun 5, 2018
MyRepublic
|
Private Equity(PE) | $60M | Internet | Yes |